Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Precision Therapeutics Reports Third Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 0.83 (-6.18%)
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer.

AIPT : 0.83 (-6.18%)
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that management...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 0.83 (-6.18%)
Precision Therapeutics' CEO Talks with Uptick Newswire's Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What's on the Horizon

Precision Therapeutics (Nasdaq: AIPT) (The "Company") is a company applying artificial intelligence to personalized medicine and drug discovery. Their CEO, Dr. Carl Schwartz, and Richard Gabriel, a consultant...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Hector J....

AIPT : 0.83 (-6.18%)
Precision Therapeutics Secures First STREAMWAY System Sale in Europe

MINNEAPOLIS, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company") is pleased to announce it has secured its first European sale of the STREAMWAY...

AIPT : 0.83 (-6.18%)
SKLN : 1.21 (-11.03%)
Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics' Scientific Advisory Board

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Robert Murphy...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has bolstered its Scientific...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 0.83 (-6.18%)
MRK : 74.84 (unch)
Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New 'HelomicsDiscover' Program to Drive Forward the Next Generation of Precision Cancer Therapies

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System

EQNX::TICKER_START (Nasdaq:AIPT), EQNX::TICKER_END

AIPT : 0.83 (-6.18%)
Precision Therapeutics Reports First Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 0.83 (-6.18%)
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...

AIPT : 0.83 (-6.18%)
Technical Perspectives on Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Retractable Technologies, and Tandem Diabetes Care

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OSUR, AIPT, RVP, and TNDM which can be accessed for free by signing up to www.wallstequities.com/registration....

AIPT : 0.83 (-6.18%)
OSUR : 13.10 (+4.13%)
TNDM : 32.90 (-0.66%)
RVP : 0.70 (+4.48%)
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 0.83 (-6.18%)
Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced...

AIPT : 0.83 (-6.18%)
SKLN : 1.21 (-11.03%)
CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

In a release issued under the same headline earlier today by Precision Therapeautics (NASDAQ:AIPT), please note that the forward-looking statements paragraph was missing. The corrected release follows:...

AIPT : 0.83 (-6.18%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV

CEOLive.TV, a news organization that highlights leading CEOs, companies, and industry experts for investors, today released a video interview with Dr. Carl Schwartz, CEO of Precision Therapeutics Inc (NASDAQ:AIPT),...

AIPT : 0.83 (-6.18%)
SKLN : 1.21 (-11.03%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA -3.87
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures are hovering close to UNCH this morning. They ended the Thursday session with most contracts steady to fractionally higher. Analysts are expecting 500,000-900,000 MT of corn was sold for export in the week of 11/8 ahead of today’s ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar